Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 8Neoplasms 4Multiple Myeloma 3Radiation Injuries 2Multiple Chronic Conditions 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Esophageal Neoplasms 2Cognitive Dysfunction 2Brain Neoplasms 2Substance-Related Disorders 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pathologic Complete Response 1Pain 1Osteosarcoma 1Neoplasms, Second Primary 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mobility Limitation 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Hyperthermia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 24Gemcitabine 16Radiotherapy, Intensity-Modulated 14Fluorouracil 7Radiotherapy 5Docetaxel 5pembrolizumab 4Surveys and Questionnaires 4Carboplatin 4Bevacizumab 4toripalimab 3spartalizumab 3camrelizumab 3Induction Chemotherapy 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Psychiatric Rehabilitation 2Paclitaxel 2Nivolumab 2Immunohistochemistry 2Drug Therapy 2Chemoradiotherapy 2Celecoxib 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Neoplasms × Patient Reported Outcome Measures × Clear all
NCT06019130 2024-05-16

NPC-Nivo

German Society for Pediatric Oncology and Hematology GPOH gGmbH

Phase 2 Recruiting
57 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡